Morgan L. Levy

1.5k total citations · 1 hit paper
8 papers, 1.1k citations indexed

About

Morgan L. Levy is a scholar working on Psychiatry and Mental health, Neurology and Physiology. According to data from OpenAlex, Morgan L. Levy has authored 8 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 2 papers in Neurology and 2 papers in Physiology. Recurrent topics in Morgan L. Levy's work include Dementia and Cognitive Impairment Research (5 papers), Alzheimer's disease research and treatments (2 papers) and Mental Health and Psychiatry (2 papers). Morgan L. Levy is often cited by papers focused on Dementia and Cognitive Impairment Research (5 papers), Alzheimer's disease research and treatments (2 papers) and Mental Health and Psychiatry (2 papers). Morgan L. Levy collaborates with scholars based in United States, France and Israel. Morgan L. Levy's co-authors include Jeffrey L. Cummings, Bruce L. Miller, Lynn A. Fairbanks, Irene Litvan, Jane S. Paulsen, Donna Masterman, Ismaël Mena, Keith W. Boone, A. Darby and Nancy Berman and has published in prestigious journals such as Neurology, Biological Psychiatry and Gerontology.

In The Last Decade

Morgan L. Levy

8 papers receiving 1.1k citations

Hit Papers

Apathy Is Not Depression 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morgan L. Levy United States 7 667 375 354 263 114 8 1.1k
Kazuhiko Hokoishi Japan 17 697 1.0× 311 0.8× 202 0.6× 193 0.7× 80 0.7× 33 1.1k
Hannah Fox United Kingdom 10 628 0.9× 482 1.3× 384 1.1× 284 1.1× 125 1.1× 18 1.3k
Yoshitaka Ikejiri Japan 20 549 0.8× 287 0.8× 188 0.5× 417 1.6× 190 1.7× 37 1.1k
Jette Stokholm Denmark 17 586 0.9× 287 0.8× 217 0.6× 294 1.1× 107 0.9× 36 1.0k
M. S. Barquero Spain 14 580 0.9× 268 0.7× 163 0.5× 470 1.8× 82 0.7× 22 1.3k
Shunichiro Shinagawa Japan 24 913 1.4× 560 1.5× 261 0.7× 302 1.1× 127 1.1× 96 1.6k
Alejandra Tesón United States 10 722 1.1× 228 0.6× 223 0.6× 302 1.1× 64 0.6× 12 1.1k
Byung Hwa Lee South Korea 18 633 0.9× 302 0.8× 208 0.6× 443 1.7× 52 0.5× 48 1.2k
D. Massari Italy 8 359 0.5× 157 0.4× 177 0.5× 380 1.4× 66 0.6× 10 1.1k
Pilar Santacruz Spain 16 345 0.5× 255 0.7× 302 0.9× 182 0.7× 189 1.7× 28 917

Countries citing papers authored by Morgan L. Levy

Since Specialization
Citations

This map shows the geographic impact of Morgan L. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan L. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan L. Levy more than expected).

Fields of papers citing papers by Morgan L. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan L. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan L. Levy. The network helps show where Morgan L. Levy may publish in the future.

Co-authorship network of co-authors of Morgan L. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan L. Levy. A scholar is included among the top collaborators of Morgan L. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan L. Levy. Morgan L. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bregman, Noa, Morgan L. Levy, Eyal Lotan, et al.. (2025). Lecanemab in clinical practice: real-world outcomes in early Alzheimer’s disease. Alzheimer s Research & Therapy. 17(1). 119–119. 2 indexed citations
2.
Levy, Morgan L., et al.. (1999). Neuropsychiatric Symptoms and Cholinergic Therapy for Alzheimer’s Disease. Gerontology. 45(Suppl. 1). 15–22. 97 indexed citations
3.
Levy, Morgan L., Jeffrey L. Cummings, Lynn A. Fairbanks, David L. Sultzer, & Gary W. Small. (1999). Apolipoprotein E genotype and noncognitive symptoms in Alzheimer’s disease. Biological Psychiatry. 45(4). 422–425. 61 indexed citations
4.
Levy, Morgan L., Jeffrey L. Cummings, Lynn A. Fairbanks, et al.. (1998). Apathy Is Not Depression. Journal of Neuropsychiatry. 10(3). 314–319. 508 indexed citations breakdown →
5.
Miller, Bruce L., Marcel O. Pontón, Morgan L. Levy, et al.. (1997). A study of the Lund‐Manchester research criteria for frontotemporal dementia. Neurology. 48(4). 937–941. 167 indexed citations
6.
Levy, Morgan L.. (1996). Alzheimer Disease and Frontotemporal Dementias. Archives of Neurology. 53(7). 687–687. 222 indexed citations
7.
Levy, Morgan L., et al.. (1996). Neuropsychiatric Syndromes in Neurodegenerative Disease: Frequency and Signficance.. PubMed. 1(4). 241–247. 37 indexed citations
8.
Cathébras, P., et al.. (1994). [Screening for depression in patients with medical hospitalization. Comparison of two self-evaluation scales and clinical assessment with a structured questionnaire].. PubMed. 20(3). 311–7. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026